From the Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520 and; the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou 510060, China.
From the Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520 and.
J Biol Chem. 2010 Feb 5;285(6):3750-3757. doi: 10.1074/jbc.M109.069385. Epub 2009 Nov 30.
Toll-like receptor 4 (TLR4) is unique among the Toll-like receptors in its ability to utilize TLR/IL1R-domain-containing adaptor protein (TIRAP), which recruits TLR4-MyD88 to phosphatidylinositol 4,5-bisphosphate (PIP(2))-rich sites on the plasma membrane, to activate NF-kappaB and MAPK pathways. Here, we show that AIP1 disrupts formation of the TLR4- TIRAP-MyD88 complex without directly binding to any of the complex components. AIP1 via its pleckstrin homology and C2 domains binds to phosphatidylinositol 4-phosphate, a lipid precursor of PIP(2). Knock-out of AIP1 in cells increases and overexpression of AIP1 reduces cellular PIP(2) levels. We further show that AIP1 is a novel GTPase-activating protein (GAP) for Arf6, a small GTPase regulating cellular PIP(2) production and formation of the TLR4-TIRAP-MyD88 complex. Thus, deletion of the GAP domain on AIP1 results in a loss of its ability to mediate the inhibition of Arf6- and TLR4-induced signaling events. We conclude that AIP1 functions as a novel Arf6-GAP to negatively regulate PIP(2)-dependent TLR4-TIRAP-MyD88 signaling.
Toll 样受体 4(TLR4)在其能够利用 Toll/IL1R 结构域包含衔接蛋白(TIRAP)的能力方面是独特的,TIRAP 招募 TLR4-MyD88 到质膜上富含磷脂酰肌醇 4,5-二磷酸(PIP(2))的位点,以激活 NF-κB 和 MAPK 途径。在这里,我们表明 AIP1 破坏 TLR4-TIRAP-MyD88 复合物的形成,而不直接与复合物的任何成分结合。AIP1 通过其 pleckstrin 同源和 C2 结构域与磷脂酰肌醇 4-磷酸结合,后者是 PIP(2)的脂质前体。细胞中 AIP1 的敲除会增加和过表达 AIP1 会降低细胞内 PIP(2)水平。我们进一步表明,AIP1 是 Arf6 的一种新型 GTP 酶激活蛋白(GAP),Arf6 是一种调节细胞 PIP(2)产生和 TLR4-TIRAP-MyD88 复合物形成的小 GTPase。因此,AIP1 上 GAP 结构域的缺失导致其介导 Arf6 和 TLR4 诱导的信号事件抑制的能力丧失。我们得出结论,AIP1 作为一种新型的 Arf6-GAP,负调控依赖 PIP(2)的 TLR4-TIRAP-MyD88 信号转导。